BNTC earnings date and last-quarter result: next report 2026-09-28, last quarter beat, P/E -10.31. Updated 2026-07-23.
Benitec Biopharma (BNTC) Research Hub
Benitec Biopharma (BNTC) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 8.59 USD (-0.69%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -10.31, market cap 0.30B. This hub links to the full technical, earnings and options research available for BNTC.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 8.59 USD (-0.69%) |
| 52-week range | 8 USD – 13.98 USD |
| Trend regime | Range |
| 14-day RSI | 44.7 (Bearish) |
| Trailing P/E | -10.31 |
| Market cap | 0.30B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-28 |
Available research for BNTC
Covered Call on BNTC: how it works, illustrative setup around the real 8.59 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BNTC: how it works, illustrative setup around the real 8.59 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BNTC: how it works, illustrative setup around the real 8.59 USD price, max profit/loss, breakeven and when to use it. Educational.
BNTC technical analysis: range, last 8.59 USD, RSI 44.7, 52w range 8 USD–13.98 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is BNTC in?
Benitec Biopharma (BNTC) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is BNTC in an uptrend or downtrend?
As of 2026-10-26, BNTC is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BNTC's trailing P/E ratio?
BNTC's trailing P/E is -10.31, with a market cap of 0.30B. See the earnings research page for full valuation detail.
When does BNTC next report earnings?
BNTC is next scheduled to report earnings on 2026-09-28.